by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersDiamond-Herpanacine of PA, Inc.

All Warning Letters

Diamond-Herpanacine of PA, Inc.

Warning LetterOpen

Diamond-Herpanacine of PA, Inc., 1518 Grove Avenue Jenkintown , PA 19046-2302 United StatesIssued Jan 22, 2026Human Foods Program

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateJan 22, 2026

Product TypeDietary Supplements

StatusOpen

Letter Details

Firm: Diamond-Herpanacine of PA, Inc.
Location: Diamond-Herpanacine of PA, Inc., 1518 Grove Avenue Jenkintown , PA 19046-2302 United States
FEI Number: N/A
Country: United States
Issue Date: January 22, 2026
Issuing Office: Human Foods Program
Product Type: Dietary Supplements
Status: Open

Subject

New Drug/Misbranded

Diamond-Herpanacine of PA, Inc. FDA Warning Letter, January 22, 2026